Evaluation of the effectiveness of inhaled furosemide in patients with acute asthma attack
Phase 3
- Conditions
- ???.Asthma
- Registration Number
- IRCT20180522039784N2
- Lead Sponsor
- Karaj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Satisfaction to participate in the study
Asthma diagnosis
The incidence of mild to moderate asthma attack (the clinical criterion of asthma 1 to 6)
Ability to perform respiratory tests
Exclusion Criteria
Start over 10 hours of symptoms
History of smoking over 10 pack-year
Simultaneous acute illness
Pregnancy
Beta 2 agonist consumption in 6 hours before referral
Pneumonia
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method First second of forced expiration. Timepoint: Before starting treatment, 15, 30 and 45 minutes. Method of measurement: Bionet SPM-7 Spirometr device.;Peak expiratory flow rate. Timepoint: Before starting treatment, 15, 30 and 45 minutes. Method of measurement: Bionet SPM-7 Spirometr device.
- Secondary Outcome Measures
Name Time Method Heart rate. Timepoint: Before starting treatment, 15, 30 and 45 minutes. Method of measurement: The heart rate per minute by examination.;Respiratory rate. Timepoint: Before starting treatment, 15, 30 and 45 minutes. Method of measurement: The respiratory rate per minute by examination.;Clinical criteria of asthma. Timepoint: Before starting treatment, 15, 30 and 45 minutes. Method of measurement: Clinical Criterion of Asthma (CAS).